Raising the Index of Suspicion in Primary Care: The Critical Role of the Nurse Practitioner in Improving Referral Rates, Diagnosis and Outcomes in Pulmonary Hypertension

Access Activity

Overview / Abstract:

Target Audience
This educational initiative has been designed for nurse practitioners, physician assistants, and physicians who practice in primary care and specialty settings.

Program Overview
Pulmonary Arterial Hypertension (PAH) poses a challenge for clinical practice due to delayed diagnosis and suboptimal treatment and management. As a result, patients with PAH report a poor quality of life and are associated with a huge healthcare burden. Given the complexities of screening, diagnosis and treatment of PAH, a multidisciplinary approach is critical to improving outcomes for patients, and the role of the nurse practitioner (NP) has become all the more pivotal.

This program will utilize integrated case studies to illustrate the journey of a patient with PAH to facilitate early recognition and diagnosis. The program will provide guidance on updated approaches for diagnosis and distinguishing PAH from other disorders with similar presentations. Experts will clarify the utility of available and emerging therapies for PAH and provide recommendations to design patient-centered treatment plans and ensure patient satisfaction with treatment that will aim to improve quality of life.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Recognize the role for the NP to improve patient outcomes in PAH
Differentiate symptoms and signs of PAH from disorders with similar presentations to help improve early referral and recognition of the disease
Discuss how to develop a patient-centered, guideline-directed, evidence-based management plan for PAH that includes consideration of novel therapies and current clinical trial data
Describe the patient experience for patients with PAH

Expiration

May 26, 2022

Discipline(s)

Physician CME

Format

Online

Credits / Hours

1.0

Accreditation

ACCME, AANP

Presenters / Authors / Faculty

Vallerie V. McLaughlin, MD
Martha Kingman, DNP, FNP-C

Sponsors / Supporters / Grant Providers

Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

Keywords / Search Terms

Relias LLC Relias, Free CME, Pulmonary Hypertension Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map